EUVIMEDEUVIMED entdecken
Crossref

EE470 ECONOMIC IMPACT OF EARLIER DETECTION AND THERAPEUTIC MANAGEMENT OF LEPTOMENINGEAL METASTASES USING CNSIDE: A COST-OF-CARE ANALYSIS

Kelly K. Ondrasek, Russell Havranek, Randy Goodman

Value in Health · 2026-06 · 29 (6) · S152

DOI: 10.1016/j.jval.2026.03.763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Value in Health, 2026-06. Verfasst von Kelly K. Ondrasek und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Ondrasek, K. K., Havranek, R., & Goodman, R. (2026). EE470 ECONOMIC IMPACT OF EARLIER DETECTION AND THERAPEUTIC MANAGEMENT OF LEPTOMENINGEAL METASTASES USING CNSIDE: A COST-OF-CARE ANALYSIS. Value in Health, 29(6), S152. https://doi.org/10.1016/j.jval.2026.03.763

Vancouver

Ondrasek KK, Havranek R, Goodman R. EE470 ECONOMIC IMPACT OF EARLIER DETECTION AND THERAPEUTIC MANAGEMENT OF LEPTOMENINGEAL METASTASES USING CNSIDE: A COST-OF-CARE ANALYSIS. Value in Health. 2026;29(6):S152. doi:10.1016/j.jval.2026.03.763

BibTeX
@article{Ondrasek2026,
  author = {Ondrasek, Kelly K. and Havranek, Russell and Goodman, Randy},
  title = {EE470 ECONOMIC IMPACT OF EARLIER DETECTION AND THERAPEUTIC MANAGEMENT OF LEPTOMENINGEAL METASTASES USING CNSIDE: A COST-OF-CARE ANALYSIS},
  journal = {Value in Health},
  year = {2026},
  volume = {29},
  number = {6},
  pages = {S152},
  doi = {10.1016/j.jval.2026.03.763}
}
Kostenlos starten →